Press Releases

Rheonix to Present Data on User-Defined Tests and Next-Generation Sequencing Library Preparation with its Automated Molecular Testing Workstation

Company to showcase technology at AMP 2016 that streamlines assay workflows and improves efficiencies in research and clinical environments ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will highlight its Encompass Optimum™ workstation at the Association for Molecular Pathology (AMP) Annual Meeting Nov. 10-12 in Charlotte, North Carolina. The workstation simplifies many of the steps required to create customized user-defined assays by automating test performance and… Read More »

Rheonix Launches Revolutionary Technology for Rapid Detection of Beer Spoilers

Beer SpoilerAlert™ assay and Encompass Optimum™ workstation enable next-day detection of spoilage organisms and hops-resistance genes ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, announces the launch of its Beer SpoilerAlert™ assay for use on the Encompass Optimum™ workstation. This is the first fully automated assay for detecting beer spoilage organisms and the first assay to simultaneously detect microorganisms and hops-resistance genes. Rheonix will showcase this new… Read More »

Rheonix Announces New Food Testing Leadership and Introduces the Fully Automated Encompass Optimum™ Workstation for Food and Beverage Testing

Rheonix expands its management team with the addition of two food safety executives. Introduction of the easy-to-use workstation concurs with the International Association for Food Protection (IAFP) Annual Meeting in St. Louis. ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, announces its expansion in food and beverage testing with the introduction of the Encompass Optimum™ workstation for food and beverage testing and the hiring of two… Read More »

Rheonix to Highlight Automated Microfluidic Workstation for Molecular Testing at AACC Clinical Lab Expo

Automated technology increases efficiencies and lowers total cost of ownership for laboratories ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will highlight its research-use-only Encompass Optimum™ workstation at the 68th American Association of Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Lab Expo on July 31-Aug. 4 in Philadelphia, Pennsylvania. The workstation performs fully automated, complex molecular assays in an easy-to-use and economical format, addressing workflow… Read More »

Rheonix to Showcase Automated Molecular Testing Technology that Increases Efficiencies in Research Laboratories at ASM Microbe 2016

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will showcase its research-use-only Encompass Optimum™ workstation at ASM Microbe 2016 on June 16-20 at the Boston Convention and Exhibition Center in Boston, Massachusetts. The workstation performs fully automated, complex molecular assays in an easy-to-use and economical format, addressing workflow and staffing obstacles that research laboratories are facing today. The Encompass Optimum workstation, when integrated with a Rheonix… Read More »

Rheonix to Showcase Fully Automated Microfluidic Molecular Testing Technology at 32nd Annual Clinical Virology Symposium

ITHACA, N.Y. — Rheonix, Inc., a developer of fully automated molecular testing solutions, will showcase its research-use-only Encompass Optimum™ workstation at the 32nd Annual Clinical Virology Symposium and Annual Meeting of the Pan American Society for Clinical Virology on May 19-22 at the Hilton Daytona Beach in Daytona Beach, Florida. The workstation performs fully automated, complex molecular assays in an easy-to-use and economical format, addressing workflow and staffing obstacles that… Read More »

Rheonix to Pursue Rapid Zika Virus Diagnostic

ITHACA, N.Y. — Rheonix, Inc., a developer of fully automated molecular testing solutions, in collaboration with New York University College of Dentistry (NYUCD), has received funding to develop a rapid diagnostic for Zika virus infection. The $656,414 award is an administrative supplement to an existing Small Business Innovation Research (SBIR) Phase I/II Fast-track grant from the National Institute of Dental and Craniofacial Research (NIDCR) of the National Institutes of Health… Read More »

Rheonix Develops Fully Automated Microfluidic System that Improves HIV Testing

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, has completed development and testing of a microfluidic system and assay to simultaneously detect host anti-HIV antibodies and viral RNA in a single specimen of saliva or blood. The company’s findings are outlined in the recently published research article, “A Rapid, Self-confirming Assay for HIV: Simultaneous Detection of Anti-HIV Antibodies and Viral RNA” in the Journal of… Read More »

Rheonix to Present on Industrial Automation Solutions in the Lab at SLAS 2016

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will showcase its breakthrough molecular testing workstation, the Encompass Optimum™, in booth 537 at the Society for Laboratory Automation and Screening’s (SLAS) fifth annual conference and exhibition. The exhibition will be held at the San Diego Convention Center, Jan. 23-27. Rheonix will also participate in Festo Corp.’s workshop, “How Industrial Automation Solutions Improve Processes in the Lab… Read More »

Rheonix Inc. Raises $28.6 Million to Further Expand Commercialization Efforts of Molecular Diagnostic Technology

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, raised $28.6 million to further expand the company’s commercialization efforts for its breakthrough molecular testing platforms, the Encompass MDx® and Encompass Optimum™. The investment will also enable new product development and fund existing business needs. The funds are a combination of investments from existing international and domestic investors. Domestic investors include Advantage Capital Partners, Cayuga Venture Fund,… Read More »
Page 1 of 712345...Last »

Archives